Cancer center gets gift from Lemieux Foundation to fund project
By Pittsburgh The Tribune-Review
Published: Wednesday, Dec. 1, 2010
A $3 million gift from the Mario Lemieux Foundation has enabled the University of Pittsburgh Cancer Institute and UPMC Cancer Centers to conclude a five-year, $100 million capital campaign, officials said Tuesday.
The money will establish the Mario Lemieux Center for Blood Diseases at Hillman Cancer Center. UPMC matched the donations, to put $200 million toward the campaign that began with a $20 million gift from the Henry L. Hillman Foundation and the Hillman Foundation. The money will help with recruitment of physicians and researchers.
The Lemieux center will offer treatment for an estimated 25,000 patients a year with blood diseases. Penguins owner Lemieux, who chairs the foundation, said it has begun to focus on patient care "for those experiencing the same things I did during my journey with Hodgkin's disease."
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
Subscribe today! Click here for our subscription offers.